Abstract
Background: Optic neuritis (ON) is an inflammatory optic neuropathy, where the genetic and autoimmune dependency remains poorly characterized. Objective: To investigate autoimmune and immunogenetic aspects of ON. Method: In a prospective population-based cohort 51 patients with ON were included. At follow up 20 patients had progressed to multiple sclerosis (MS-ON). All patients were screened for neuronal and systemic autoantibodies. HLA genotypes and allele and genotype frequencies of the PTPN22 C1858T and the PD-1.3 single-nucleotide polymorphisms (SNPs) were determined and compared to a cohort of Danish blood donors, acting as healthy controls. Results: Median follow-up was 366 days (301−430) for MS-ON patients and 375 (range 50–436) for isolated ON (ION). Autoantibodies against myelin oligodendrocyte glycoprotein (MOG-IgG), were positive in two patients, no patients had anti-aquaporin-4 antibodies. Coexisting neural autoantibodies were detected in two patients and in 12 patients other systemic autoantibodies were found. Four (8%) had other autoimmune disorders. A family history of autoimmunity was observed in 12 (24%) and of demyelinating disease in six patients (12%). In MS-ON patients the frequencies of HLA-DQB1*06:02 and HLA-DRB1*15:01 tended to be higher compared to controls (p = 0.08). Stratification of patients with presence of oligoclonal bands (OCB) showed an association to the HLA-DQB1*06:02-HLA-DRB1*15:01 haplotype in ION (HLA-DQB1*06:02 and HLA-DRB1*15:01 (p = 0.03)), and in MS-ON patients (HLA-DQB1*06:02 and HLA-DRB1*15:01 (p = 0.03)). No significant associations to PTPN22 1858C/T or PD-1.3 G/A were found in any group comparison. Conclusions: ON patients had a general susceptibility to autoimmunity and two were MOG-IgG positive. HLA-DQB1*06:02 and HLA-DRB1*15:01 were associated with the presence of OCB in ON patients.
| Original language | English |
|---|---|
| Pages (from-to) | 97-102 |
| Number of pages | 6 |
| Journal | Multiple Sclerosis and Related Disorders |
| Volume | 21 |
| DOIs | |
| Publication status | Published - Apr 2018 |
Funding
K. Soelberg : No conflicts of interest. AC. Nilsson : No conflicts of interest. C. Nielsen : No conflicts of interest. S. Jarius : No conflicts of interest. M. Reindl: The Neurological Research Laboratory (Medical University of Innsbruck and Tirol Kliniken, Markus Reindl) receives payments for antibody assays (AQP4- and anti-neuronal antibodies) and for AQP4- and MOG-antibody validation experiments organized by Euroimmun (Germany). Markus Reindl was supported by research grant ‘BIG WIG MS’ from the Austrian Federal Ministry of Science, Research and Economy. B. Wildemann: The work of B.W. was supported by research grants from the Dietmar-Hopp-Stiftung and from Merck Serono. S.T. Lillevang : No conflicts of interest. N. Asgari : No conflicts of interest. Appendix A
Keywords
- Genetics
- Immunology
- Multiple sclerosis
- Optic neuritis
Fingerprint
Explore the research areas of 'Autoimmune and immunogenetic profile of patients with optic neuritis in a population-based cohort'.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver